Effects of noradrenaline and galanin on duodenal motility in the isolated perfused porcine pancreatico-duodenal block.
The influence of neurotransmitters on gastrointestinal motility is different in different segments of the gastrointestinal tract. To clarify the regulation of duodenal motility, the aim of the present study was to investigate the effects of alpha-adrenoceptor agonism and blockade and of galanin on duodenal motility. The study was undertaken in the isolated perfused porcine pancreatico-duodenal block. The agents under investigation were administered arterially. Duodenal motility was measured by means of a low-compliance perfusion system using an intraluminal catheter. In addition the concentration of galanin was measured in the portal effluent. We found that spontaneous motility was abolished by noradrenaline by an effect that was counteracted by the alpha 2-adrenoceptor antagonist idazoxan. In contrast, the selective alpha 1-adrenoceptor antagonist prazosin did not influence the effect of noradrenaline. Galanin, like noradrenaline, abolished duodenal motility. Furthermore, the concentration of galanin in the portal effluent was decreased by noradrenaline by an alpha 2-adrenoceptor mediated mechanism. We conclude that alpha 2-adrenoceptor activation and galanin inhibit duodenal motility and that the release of galanin from the pancreatico-duodenal preparation is reduced by alpha 2-adrenoceptors.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D004146:Dioxanes / Q000494:pharmacology; D004386:Duodenum / Q000187:drug effects* / Q000502:physiology; D019004:Galanin; D005769:Gastrointestinal Motility / Q000187:drug effects* / Q000502:physiology; D019329:Idazoxan; D066298:In Vitro Techniques; D009479:Neuropeptides / Q000494:pharmacology / Q000502:physiology; D009638:Norepinephrine / Q000494:pharmacology* / Q000502:physiology; D010179:Pancreas / Q000187:drug effects / Q000502:physiology; D010455:Peptides / Q000494:pharmacology* / Q000502:physiology; D010477:Perfusion; D011224:Prazosin / Q000494:pharmacology; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects / Q000502:physiology; D013552:Swine
D000317:Adrenergic alpha-Antagonists; D004146:Dioxanes; D009479:Neuropeptides; D010455:Peptides; D011942:Receptors, Adrenergic, alpha; D019004:Galanin; D009638:Norepinephrine; D011224:Prazosin; D019329:Idazoxan